TY - JOUR
T1 - Comparison of left atrial appendage parameters using computed tomography vs. transesophageal echocardiography for watchman device implantation
T2 - a systematic review & meta-analysis
AU - Sattar, Yasar
AU - Kompella, Ritika
AU - Ahmad, Bachar
AU - Aamir, Muhammad
AU - Suleiman, Abdul Rahman M.
AU - Zghouzi, Mohamed
AU - Ullah, Waqas
AU - Zafrullah, Fnu
AU - Elgendy, Islam Y.
AU - Balla, Sudharshan
AU - Kawsara, Akram
AU - Alraies, M. Chadi
N1 - Publisher Copyright:
© 2022 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Background: Inaccurate sizing of left atrial appendage (LAA) occlusion devices is associated with increased stroke risk. We compared the LAA size to implant the Watchman device assessed by computed tomography (CT) to transesophageal echocardiography (TEE). Methods: Databases were searched to identify studies comparing LAA anatomical measurements and procedural outcomes across imaging modalities for the Watchman device implantation. Results: Seven studies were included in the analysis (242 patients on TEE, and 232 on CT). The LAA orifice was larger when sized with CT compared to TEE (CT mean vs TEE SMD 0.30 mm, 95%CI 0.09–0.51 mm, P < 0.01; and CT max vs TEE SMD 0.69 mm, 95%CI 0.51–0.87 mm, P < 0.001). Additionally, CT, including CT-based 3-dimensional models, had higher odds of predicting correct device size compared to TEE (OR 1.64; 95%CI 1.05–2.56; P = 0.03). CT resulted in a lower fluoroscopy time vs TEE (SMD −0.78 min, 95% CI −1.39 to −0.18, P = 0.012). No significant differences were found in device clinical outcomes. Conclusion: Compared to TEE, CT resulted in larger LAA orifice measurements, improved odds of predicting correct device size, and reduced fluoroscopy time in patients undergoing LAA occlusion with the Watchman device. There were no significant differences in other procedural outcomes.
AB - Background: Inaccurate sizing of left atrial appendage (LAA) occlusion devices is associated with increased stroke risk. We compared the LAA size to implant the Watchman device assessed by computed tomography (CT) to transesophageal echocardiography (TEE). Methods: Databases were searched to identify studies comparing LAA anatomical measurements and procedural outcomes across imaging modalities for the Watchman device implantation. Results: Seven studies were included in the analysis (242 patients on TEE, and 232 on CT). The LAA orifice was larger when sized with CT compared to TEE (CT mean vs TEE SMD 0.30 mm, 95%CI 0.09–0.51 mm, P < 0.01; and CT max vs TEE SMD 0.69 mm, 95%CI 0.51–0.87 mm, P < 0.001). Additionally, CT, including CT-based 3-dimensional models, had higher odds of predicting correct device size compared to TEE (OR 1.64; 95%CI 1.05–2.56; P = 0.03). CT resulted in a lower fluoroscopy time vs TEE (SMD −0.78 min, 95% CI −1.39 to −0.18, P = 0.012). No significant differences were found in device clinical outcomes. Conclusion: Compared to TEE, CT resulted in larger LAA orifice measurements, improved odds of predicting correct device size, and reduced fluoroscopy time in patients undergoing LAA occlusion with the Watchman device. There were no significant differences in other procedural outcomes.
KW - CT
KW - left atrial appendage closure
KW - TEE
KW - Watchman
KW - watchman FLX
UR - https://www.scopus.com/pages/publications/85126021327
UR - https://www.scopus.com/inward/citedby.url?scp=85126021327&partnerID=8YFLogxK
U2 - 10.1080/14779072.2022.2043745
DO - 10.1080/14779072.2022.2043745
M3 - Article
C2 - 35172121
AN - SCOPUS:85126021327
SN - 1477-9072
VL - 20
SP - 151
EP - 160
JO - Expert Review of Cardiovascular Therapy
JF - Expert Review of Cardiovascular Therapy
IS - 2
ER -